Lv11
46 积分 2024-10-08 加入
Novel quinazoline-based dual EGFR/c-Met inhibitors overcoming drug resistance for the treatment of NSCLC: Design, synthesis and anti-tumor activity
2小时前
待确认
Discovery of D6808, a Highly Selective and Potent Macrocyclic c-Met Inhibitor for Gastric Cancer Harboring MET Gene Alteration Treatment
12天前
已完结
The Missing Link(er): A Roadmap to Macrocyclization in Drug Discovery
1个月前
已完结
皖公网安备34019202002308
